New therapies in Hodgkin's lymphoma.
Bartlett
Nancy
N
Washington University, St. Louis, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019468:Disease Management; D006689:Hodgkin Disease / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D009367:Neoplasm Staging; D016609:Neoplasms, Second Primary / Q000139:chemically induced; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D016879:Salvage Therapy / Q000379:methods
D000911:Antibodies, Monoclonal